3Rivera M, Kim W, Wells J, Driscoll D, Brannigan B, Han M, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms' tumor. Science 2007; 315: 642-645.
4Fukuzawa R, Anaka M, Weeks R, Morison I, Reeve A. Canonical WNT signalling determines lineage specificity in Wilms' tumour. Oncogene 2009; 28: 1063-1075.
5Ruteshouser E, Robinson S, Huff V. Wilms' tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 2008; 47: 461-470.
6Perotti D, Gamba B, Sardella M, Spreafico F, Terenziani M, Collini P, et al. Functional inactivation of the WTXgene is not a frequent event in Wilms' tumors. Oncogene 2008; 27: 4625-4632.
7Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M. WTX inactivation is a frequent, but late event in Wilms' tumors without apparent clinical impact. Genes Chromosomes Cancer 2009; 48: 1102-1111.
8Guertl B, Leuschner I, Guelly C, Ebner B, Kronberger C, Hoefler G. Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene? Pathol Oncol Res 2010; 16: 189-191.
9Yoo J, Kim S, Lee H. Mutational analysis of WTX gene in Wnt/beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas. Dig Dis Sci 2009; 54: 1011-1014.
10Owen C, Virappane P, Alikian M, Stasevich I, Summers K, Lillington D, et al. WTX is rarely mutated in acute myeloid leukemia. Haematologica 2008; 93: 947-948.
